Cargando…
The clinical value of indirect immunofluorescence for screening anti-rods and rings antibodies: A retrospective study of two centers in China
OBJECTIVE: To investigate the distribution and clinical significance of the rods and rings (RR) pattern in various diseases. METHODS: A total of 169,891 patients in Peking Union Medical College Hospital (PUMCH) and 29,458 patients in Inner Mongolia People’s Hospital (IMPH) from January 2018 to Decem...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9552219/ https://www.ncbi.nlm.nih.gov/pubmed/36238277 http://dx.doi.org/10.3389/fimmu.2022.1007257 |
_version_ | 1784806206546640896 |
---|---|
author | Meng, Jingjing Yang, Guoxiang Li, Siting Luo, Yueming Bai, Yina Deng, Chuiwen Song, Ning Li, Mengtao Zeng, Xiaofeng Hu, Chaojun |
author_facet | Meng, Jingjing Yang, Guoxiang Li, Siting Luo, Yueming Bai, Yina Deng, Chuiwen Song, Ning Li, Mengtao Zeng, Xiaofeng Hu, Chaojun |
author_sort | Meng, Jingjing |
collection | PubMed |
description | OBJECTIVE: To investigate the distribution and clinical significance of the rods and rings (RR) pattern in various diseases. METHODS: A total of 169,891 patients in Peking Union Medical College Hospital (PUMCH) and 29,458 patients in Inner Mongolia People’s Hospital (IMPH) from January 2018 to December 2020 were included, and the results of ANA (antinuclear antibodies) and special antibodies were analyzed retrospectively. RESULTS: The positive rates of ANA and RR patterns were 34.84%, 0.16% in PUMCH, and 44.73%, 0.23% in IMPH. Anti-RR antibodies mainly appear in adults (≥ 41 years), mostly of low or medium fluorescence titers. Isolated RR patterns were mostly presented (60.30% and 69.12%, respectively), and the RR pattern mixed with the speckled pattern was most commonly observed among patients having two or more patterns. The RR pattern existed in a variety of diseases including hepatitis C, AIDs, pulmonary diseases, nephropathy diseases, and even healthy people. The highest prevalence of the RR pattern was observed in hepatic diseases, such as hepatic dysfunction (0.79%), hepatic cirrhosis (1.05%), PBC (0.85%), and AIH (0.65%), etc. The positive rate of specific antibodies in RR pattern cases was 31.25%, and anti-Ro52 (27, 20.61%) was the most common target antibody. CONCLUSION: The RR pattern had a low prevalence in ANAs test samples and varied in different nationalities and regions. Except for hepatitis C, it could be observed in AIDs, pulmonary diseases, nephropathy, other hepatic diseases, and even healthy people, but the positive rate was slightly higher in hepatic diseases. Its mechanism of action and clinical relevance still need clarification. |
format | Online Article Text |
id | pubmed-9552219 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-95522192022-10-12 The clinical value of indirect immunofluorescence for screening anti-rods and rings antibodies: A retrospective study of two centers in China Meng, Jingjing Yang, Guoxiang Li, Siting Luo, Yueming Bai, Yina Deng, Chuiwen Song, Ning Li, Mengtao Zeng, Xiaofeng Hu, Chaojun Front Immunol Immunology OBJECTIVE: To investigate the distribution and clinical significance of the rods and rings (RR) pattern in various diseases. METHODS: A total of 169,891 patients in Peking Union Medical College Hospital (PUMCH) and 29,458 patients in Inner Mongolia People’s Hospital (IMPH) from January 2018 to December 2020 were included, and the results of ANA (antinuclear antibodies) and special antibodies were analyzed retrospectively. RESULTS: The positive rates of ANA and RR patterns were 34.84%, 0.16% in PUMCH, and 44.73%, 0.23% in IMPH. Anti-RR antibodies mainly appear in adults (≥ 41 years), mostly of low or medium fluorescence titers. Isolated RR patterns were mostly presented (60.30% and 69.12%, respectively), and the RR pattern mixed with the speckled pattern was most commonly observed among patients having two or more patterns. The RR pattern existed in a variety of diseases including hepatitis C, AIDs, pulmonary diseases, nephropathy diseases, and even healthy people. The highest prevalence of the RR pattern was observed in hepatic diseases, such as hepatic dysfunction (0.79%), hepatic cirrhosis (1.05%), PBC (0.85%), and AIH (0.65%), etc. The positive rate of specific antibodies in RR pattern cases was 31.25%, and anti-Ro52 (27, 20.61%) was the most common target antibody. CONCLUSION: The RR pattern had a low prevalence in ANAs test samples and varied in different nationalities and regions. Except for hepatitis C, it could be observed in AIDs, pulmonary diseases, nephropathy, other hepatic diseases, and even healthy people, but the positive rate was slightly higher in hepatic diseases. Its mechanism of action and clinical relevance still need clarification. Frontiers Media S.A. 2022-09-27 /pmc/articles/PMC9552219/ /pubmed/36238277 http://dx.doi.org/10.3389/fimmu.2022.1007257 Text en Copyright © 2022 Meng, Yang, Li, Luo, Bai, Deng, Song, Li, Zeng and Hu https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Immunology Meng, Jingjing Yang, Guoxiang Li, Siting Luo, Yueming Bai, Yina Deng, Chuiwen Song, Ning Li, Mengtao Zeng, Xiaofeng Hu, Chaojun The clinical value of indirect immunofluorescence for screening anti-rods and rings antibodies: A retrospective study of two centers in China |
title | The clinical value of indirect immunofluorescence for screening anti-rods and rings antibodies: A retrospective study of two centers in China |
title_full | The clinical value of indirect immunofluorescence for screening anti-rods and rings antibodies: A retrospective study of two centers in China |
title_fullStr | The clinical value of indirect immunofluorescence for screening anti-rods and rings antibodies: A retrospective study of two centers in China |
title_full_unstemmed | The clinical value of indirect immunofluorescence for screening anti-rods and rings antibodies: A retrospective study of two centers in China |
title_short | The clinical value of indirect immunofluorescence for screening anti-rods and rings antibodies: A retrospective study of two centers in China |
title_sort | clinical value of indirect immunofluorescence for screening anti-rods and rings antibodies: a retrospective study of two centers in china |
topic | Immunology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9552219/ https://www.ncbi.nlm.nih.gov/pubmed/36238277 http://dx.doi.org/10.3389/fimmu.2022.1007257 |
work_keys_str_mv | AT mengjingjing theclinicalvalueofindirectimmunofluorescenceforscreeningantirodsandringsantibodiesaretrospectivestudyoftwocentersinchina AT yangguoxiang theclinicalvalueofindirectimmunofluorescenceforscreeningantirodsandringsantibodiesaretrospectivestudyoftwocentersinchina AT lisiting theclinicalvalueofindirectimmunofluorescenceforscreeningantirodsandringsantibodiesaretrospectivestudyoftwocentersinchina AT luoyueming theclinicalvalueofindirectimmunofluorescenceforscreeningantirodsandringsantibodiesaretrospectivestudyoftwocentersinchina AT baiyina theclinicalvalueofindirectimmunofluorescenceforscreeningantirodsandringsantibodiesaretrospectivestudyoftwocentersinchina AT dengchuiwen theclinicalvalueofindirectimmunofluorescenceforscreeningantirodsandringsantibodiesaretrospectivestudyoftwocentersinchina AT songning theclinicalvalueofindirectimmunofluorescenceforscreeningantirodsandringsantibodiesaretrospectivestudyoftwocentersinchina AT limengtao theclinicalvalueofindirectimmunofluorescenceforscreeningantirodsandringsantibodiesaretrospectivestudyoftwocentersinchina AT zengxiaofeng theclinicalvalueofindirectimmunofluorescenceforscreeningantirodsandringsantibodiesaretrospectivestudyoftwocentersinchina AT huchaojun theclinicalvalueofindirectimmunofluorescenceforscreeningantirodsandringsantibodiesaretrospectivestudyoftwocentersinchina AT mengjingjing clinicalvalueofindirectimmunofluorescenceforscreeningantirodsandringsantibodiesaretrospectivestudyoftwocentersinchina AT yangguoxiang clinicalvalueofindirectimmunofluorescenceforscreeningantirodsandringsantibodiesaretrospectivestudyoftwocentersinchina AT lisiting clinicalvalueofindirectimmunofluorescenceforscreeningantirodsandringsantibodiesaretrospectivestudyoftwocentersinchina AT luoyueming clinicalvalueofindirectimmunofluorescenceforscreeningantirodsandringsantibodiesaretrospectivestudyoftwocentersinchina AT baiyina clinicalvalueofindirectimmunofluorescenceforscreeningantirodsandringsantibodiesaretrospectivestudyoftwocentersinchina AT dengchuiwen clinicalvalueofindirectimmunofluorescenceforscreeningantirodsandringsantibodiesaretrospectivestudyoftwocentersinchina AT songning clinicalvalueofindirectimmunofluorescenceforscreeningantirodsandringsantibodiesaretrospectivestudyoftwocentersinchina AT limengtao clinicalvalueofindirectimmunofluorescenceforscreeningantirodsandringsantibodiesaretrospectivestudyoftwocentersinchina AT zengxiaofeng clinicalvalueofindirectimmunofluorescenceforscreeningantirodsandringsantibodiesaretrospectivestudyoftwocentersinchina AT huchaojun clinicalvalueofindirectimmunofluorescenceforscreeningantirodsandringsantibodiesaretrospectivestudyoftwocentersinchina |